Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Rat Serum Albumin, His Tag (Cat. No. RSA-R52H1) immobilized on CM5 Chip can bind Rat FCGRT&B2M Heterodimer Protein, His Tag&Strep II Tag (Cat. No. FCM-R5287) with an affinity constant of 4.98 μM as determined in a SPR assay (Biacore 8K) (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Human albumin (Hebei Da'an Pharmaceutical) | Approved | Hebei Daan Pharmaceutical Co Ltd | Mainland China | Respiratory Distress Syndrome, Adult; Fibrosis; Shock, Hemorrhagic | Hebei Daan Pharmaceutical Co Ltd | 2002-01-31 | Fibrosis; Respiratory Distress Syndrome, Adult; Shock, Hemorrhagic | Details | ||
| Human albumin(Tonrol Bio-Pharmaceutical) | Approved | Mainland China | Hypovolemia | Tonrol Bio-Pharmaceutical Co Ltd | 1996-01-01 | Hypovolemia | Details | |||
| Human Albumin(Guangdong Danxia) | Approved | Guangdong Danxia Biological Pharmaceutical Co Ltd | Mainland China | Hypovolemia | Guangdong Danxia Biological Pharmaceutical Co Ltd | 2012-10-30 | Hypovolemia | Details | ||
| Human Albumin(Anhui Da'An) | Approved | Mainland China | Tonrol Bio-Pharmaceutical Co Ltd | 2002-01-31 | Details | |||||
| Human Albumin(Huhan Nanyue) | Approved | Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd | Mainland China | Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd | 1994-01-01 | Details | ||||
| Albumin Human(Cis Bio International) | Approved | Cis Bio International Sa | Pulmocis | EU | Cis Bio International Sa | 2020-04-06 | Details | |||
| Human albumin (Hualan Biological Engineering) | Approved | Hualan Genetic Engineering Co Ltd | Mainland China | Anemia, Hemolytic, Autoimmune; Hypoalbuminemia; Hemorrhage; Hypovolemia | Hualan Genetic Engineering Co Ltd | 1995-01-01 | Hypovolemia; Hemorrhage; Anemia, Hemolytic, Autoimmune; Hypoalbuminemia | Details | ||
| 20% Human albumin (Hemarus Therapeutics) | Approved | Hemarus Therapeutics | Hemalb | India | Respiratory Distress Syndrome, Adult; Nephrotic Syndrome; Hypoalbuminemia; Hypovolemia | Hemarus Therapeutics | 2015-08-01 | Hypovolemia; Respiratory Distress Syndrome, Adult; Hypoalbuminemia; Nephrotic Syndrome | Details | |
| Human albumin (Guizhou Taibang Biological Products) | Approved | Guizhou Taibang Biological Products Co Ltd | Mainland China | Respiratory Distress Syndrome, Adult; Fibrosis; Shock, Hemorrhagic | Guizhou Taibang Biological Products Co Ltd | 1998-01-01 | Fibrosis; Respiratory Distress Syndrome, Adult; Shock, Hemorrhagic | Details | ||
| Albumin Human (Biotest Pharma GmbH) | Approved | Biotest Pharma Gmbh | Albiomin, Albiomin 5%, Albiomin 10% | Mainland China | Hypovolemia | Biotest Pharma Gmbh | 2008-12-18 | Hypovolemia | Details | |
| Human Serum Albumin (Green Cross) | Approved | Green Cross China Biological Products Co Ltd | Mainland China | Hypovolemia | Green Cross China Biological Products Co Ltd | 1998-01-01 | Hypovolemia | Details | ||
| Albumin Human(Sanquin Plasma Products) | Approved | Sanquin Plasma Products Bv | Details | |||||||
| Human Albumin (SK Plasma) | Approved | Sk Plasma Co Ltd | Mainland China | Sk Plasma Co Ltd | 2010-03-15 | Details | ||||
| Vialebex (LFB SA/Swedish Orphan Biovitrum AB) | Approved | Lfb Biotechnologies Sas, Swedish Orphan Biovitrum Ag | France | Hypotension; Shock | null | 2013-02-01 | Hypotension; Shock | Details | ||
| Ozoralizumab | PF-5230896; PF-05230896; TS-152; ATN-103 | Approved | Ablynx Nv | Japan | Arthritis, Rheumatoid | Taisho Pharmaceutical Co Ltd | 2022-09-26 | Arthritis, Rheumatoid | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Perfluoropropane human albumin microspheres(Hunan Jingda) | Phase 3 Clinical | Hunan Jingda Pharmaceutical Co Ltd | Liver Diseases | Details | |
| 89 Zirconium labeled GSK-3128349 | Glaxosmithkline Plc | Details | |||
| Izokibep | AFB-035; ABY-035; IMG-020; IMG020 | Phase 3 Clinical | Affibody Ab | Spondylitis, Ankylosing; Psoriasis; Arthritis, Psoriatic; Hidradenitis Suppurativa; Uveitis; Plaque psoriasis | Details |
| Gefurulimab | TPP-2511; ALXN-1720; CON-9978 | Phase 3 Clinical | Alexion Pharmaceuticals Inc | Myasthenia Gravis; Proteinuria | Details |
| Hyperoncotic human albumin | Phase 3 Clinical | Manchester University Nhs Foundation Trust | Shock, Septic; Sepsis; Shock | Details | |
| ND-021 | ND-021; NM21-1480; CS-2006; CS2006 | Phase 2 Clinical | Numab Therapeutics Ag, Cstone Pharmaceuticals | Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.
A-Z
